ACUTAASPharmaceuticals
ACUTAAS CHEMICALS LIMITED — Cash Flow Statement
₹2558.60
+0.70%
ACUTAAS CHEMICALS LIMITED Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -76.30 Cr | -189.51 Cr | -30.87 Cr | -45.69 Cr | — |
| Issuance Of Capital Stock | 499.39 Cr | 51.85 Cr | 0.00 | 300.00 Cr | — |
| Capital Expenditure | -194.64 Cr | -314.68 Cr | -96.40 Cr | -33.76 Cr | — |
| End Cash Position | 185.22 Cr | 29.70 Cr | 30.53 Cr | 10.30 Cr | — |
| Beginning Cash Position | 29.70 Cr | 30.53 Cr | 10.30 Cr | 2.68 Cr | — |
| Effect Of Exchange Rate Changes | 0.00 | 0.03 Cr | 0.00 | 0.00 | — |
| Changes In Cash | 155.52 Cr | -0.86 Cr | 20.24 Cr | 7.61 Cr | — |
| Financing Cash Flow | 261.12 Cr | 239.36 Cr | -12.25 Cr | 140.26 Cr | — |
| Interest Paid Cff | -6.20 Cr | -5.94 Cr | -2.41 Cr | -5.45 Cr | — |
| Cash Dividends Paid | -12.28 Cr | -10.93 Cr | -10.94 Cr | — | — |
| Net Common Stock Issuance | 499.39 Cr | 51.85 Cr | 0.00 | 300.00 Cr | — |
| Common Stock Issuance | 499.39 Cr | 51.85 Cr | 0.00 | 300.00 Cr | — |
| Net Issuance Payments Of Debt | -208.46 Cr | 218.08 Cr | 2.76 Cr | -135.79 Cr | — |
| Net Short Term Debt Issuance | -94.82 Cr | 88.40 Cr | 2.76 Cr | — | — |
| Net Long Term Debt Issuance | -113.64 Cr | 129.67 Cr | 0.00 | -135.79 Cr | — |
| Investing Cash Flow | -223.94 Cr | -365.39 Cr | -33.04 Cr | -120.72 Cr | — |
| Interest Received Cfi | 10.80 Cr | 2.29 Cr | 2.18 Cr | 2.58 Cr | — |
| Dividends Received Cfi | 4000.00 | 0.00 | 3000.00 | 0.00 | — |
| Net Investment Purchase And Sale | -40.10 Cr | -53.01 Cr | 61.18 Cr | -0.28 Cr | — |
| Purchase Of Investment | -40.10 Cr | -66.03 Cr | — | -0.28 Cr | — |
| Net PPE Purchase And Sale | -194.64 Cr | -314.68 Cr | -96.40 Cr | -33.76 Cr | — |
| Purchase Of PPE | -194.64 Cr | -314.68 Cr | -96.40 Cr | -33.76 Cr | — |
| Operating Cash Flow | 118.34 Cr | 125.17 Cr | 65.53 Cr | -11.93 Cr | — |
| Taxes Refund Paid | -46.74 Cr | -24.35 Cr | -24.45 Cr | -22.81 Cr | — |
| Change In Working Capital | -70.01 Cr | 17.82 Cr | -36.28 Cr | -94.21 Cr | — |
| Change In Other Current Liabilities | -2.80 Cr | 24.88 Cr | 1.81 Cr | -10.53 Cr | — |
| Change In Other Current Assets | 2.89 Cr | -24.96 Cr | 5.00 Cr | -24.71 Cr | — |
| Change In Payable | 21.44 Cr | 23.60 Cr | 23.63 Cr | 32.68 Cr | — |
| Change In Inventory | -23.21 Cr | -35.08 Cr | -7.00 Cr | -51.81 Cr | — |
| Change In Receivables | -80.72 Cr | 27.54 Cr | -65.33 Cr | -41.77 Cr | — |
| Other Non Cash Items | -4.58 Cr | 3.74 Cr | 0.23 Cr | 2.87 Cr | — |
| Stock Based Compensation | 0.93 Cr | 2.31 Cr | 0.00 | — | — |
| Provisionand Write Offof Assets | 0.00 | 31.75 Cr | 0.00 | — | — |
| Depreciation And Amortization | 26.62 Cr | 16.06 Cr | 12.34 Cr | 10.08 Cr | — |
| Depreciation | 26.62 Cr | 16.06 Cr | 12.32 Cr | 10.08 Cr | — |
| Gain Loss On Investment Securities | -6.12 Cr | -4.19 Cr | -2.13 Cr | -0.59 Cr | — |
| Gain Loss On Sale Of PPE | -0.01 Cr | -0.21 Cr | 0.75 Cr | 0.00 | — |
| Net Income From Continuing Operations | 216.16 Cr | 81.90 Cr | 112.17 Cr | 91.45 Cr | — |
| Issuance Of Debt | — | 129.67 Cr | 0.00 | — | — |
| Net Other Financing Charges | — | -13.64 Cr | — | — | — |
| Long Term Debt Issuance | — | 129.67 Cr | 0.00 | — | — |
| Net Other Investing Changes | — | -34.33 Cr | 61.12 Cr | -89.25 Cr | — |
| Sale Of Investment | — | 13.03 Cr | 61.18 Cr | — | 3.46 Cr |
| Sale Of PPE | — | 0.56 Cr | — | 0.00 | 2.54 Cr |
| Amortization Cash Flow | — | 0.16 Cr | 0.02 Cr | — | — |
| Net Foreign Currency Exchange Gain Loss | — | 0.00 | 2.90 Cr | 1.29 Cr | -1.07 Cr |
| Other Cash Adjustment Outside Changein Cash | — | — | — | -1000.00 | -12000.00 |
| Pension And Employee Benefit Expense | — | — | — | 0.81 Cr | -0.04 Cr |
| Capital Expenditure Reported | — | — | — | — | -106.58 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on ACUTAAS CHEMICALS LIMITED
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.